A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

Author: Nitayaphan S.   Khamboonruang C.   Sirisophana N.   Morgan P.   Chiu J.   Duliege A.-M.   Chuenchitra C.   Supapongse T.   Rungruengthanakit K.   deSouza M.   Mascola J.R.   Boggio K.   Ratto-Kim S.   Markowitz L.E.   Birx D.   Suriyanon V.   McNeil J.G.   Brown A.E.   Michael R.A.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.18, Iss.15, 2000-02, pp. : 1448-1455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content